PROBLEMS IN INVITRO RECEPTOR-BINDING STUDIES AND IDENTIFICATION AND ROLE OF SEROTONIN RECEPTOR-SITES

被引：68

作者：

LEYSEN, J

机构：

来源：

关键词：

D O I：

10.1016/0028-3908(84)90066-2

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：247 / 254

页数：8

共 47 条

[1] AGHAJANIAN GK, 1981, SEROTONIN NEUROTRANS, P156
[2] Awouters F, 1982, 5 HYDROXYTRYPTAMINE, P193
[3] BENNETT JP, 1976, MOL PHARMACOL, V12, P373
[4] BRISTOW DR, 1981, BRIT J PHARMACOL, V72, pP547
[5] COLPAERT FC, 1982, J PHARMACOL EXP THER, V221, P206
[6] NIGROSTRIATAL LESIONS ENHANCE STRIATAL APOMORPHINE-H-3 AND H-3-SPIROPERIDOL BINDING
CREESE, I
SNYDER, SH
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 56 (03) : 277 - 281
[7] DECLERCK F, 1982, AGENTS ACTIONS, V12, P388
[8] DECLERCK F, 1983, THROMB RES
[9] CHARACTERIZATION OF INHIBITORY 5-HYDROXYTRYPTAMINE RECEPTORS THAT MODULATE DOPAMINE RELEASE IN THE STRIATUM
ENNIS, C
KEMP, JD
COX, B
[J]. JOURNAL OF NEUROCHEMISTRY, 1981, 36 (04) : 1515 - 1520
[10] 2 KINDS OF TRYPTAMINE RECEPTOR
GADDUM, JH
PICARELLI, ZP
[J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1957, 12 (03): : 323 - 328